ConductScience.org, home

Paper6292819

Angiotensin converting enzyme inhibitors.

Soudijn W. Pharm Weekbl Sci, 1982. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Angiotensin converting enzyme inhibitors. Papers, record 6292819. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6292819

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Angiotensin converting enzyme inhibitors.
PubMed
Journal
Pharm Weekbl Sci
PubMed
Year
1982
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.33
iCite
Revised in PubMed
2019-11-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Soudijn WW

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiotensin-Converting Enzyme InhibitorsMajor topic
Animals
Captopril
Chemical Phenomena
Chemistry, Physical
Rabbits
Stereoisomerism

Source PubMed

Download CSV of topics

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16116000Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".Lancet1981https://conductscience.org/library/papers/6116000PubMed
26268131Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6268131PubMed
36282189Angiotensin converting enzyme (ACE) inhibitors.Annu Rev Pharmacol Toxicol1982https://conductscience.org/library/papers/6282189PubMed
46287131Angiotensin-converting enzyme inhibitors: medicinal chemistry and biological actions.Med Res Rev1982https://conductscience.org/library/papers/6287131PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
8597776How adverse drug reactions can play a role in innovative drug research.Pharm World Sci1995https://conductscience.org/library/papers/8597776PubMed
6316248Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs.Pharm Weekbl Sci1983https://conductscience.org/library/papers/6316248PubMed
1945742The role of medicinal chemistry in drug research.Pharm Weekbl Sci1991https://conductscience.org/library/papers/1945742PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6292819

GET https://conductscience.org/api/papers/v1/6292819/authors